Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal

To fuel its global ambitions, Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.75 billion.

Read Full Article

Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal

Related Posts

The Scottish election is becoming a farce

Asian Games years could be moved in shake-up: Reports

Australia’s military spend fell in global rankings, amid war and ‘geopolitical upheaval’

Wong Heads to Beijing, Tokyo, Seoul for Trade and Fuel Talks

Iran reportedly proposes Hormuz Strait deal to U.S. Heres where things stand and whats next for markets

Welcome Back!

Create New Account!

Retrieve your password

Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal

Related Posts

The Scottish election is becoming a farce

Asian Games years could be moved in shake-up: Reports

Australia’s military spend fell in global rankings, amid war and ‘geopolitical upheaval’

Wong Heads to Beijing, Tokyo, Seoul for Trade and Fuel Talks

Iran reportedly proposes Hormuz Strait deal to U.S. Heres where things stand and whats next for markets

Trending Topics

Welcome Back!

Create New Account!

Retrieve your password